Meningococcal Vaccine Does Not Significantly Reduce Gonorrhea Risk
A vaccine that prevents meningococcal disease did not significantly lower the risk of gonorrhea in the DoxyVAC trial, according to updated study results presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) last month in …